Scott Gottlieb - Net Worth and Insider Trading

Scott Gottlieb Net Worth

The estimated net worth of Scott Gottlieb is at least $202,705 dollars as of 2023-12-09. Scott Gottlieb is the Director of Pfizer Inc and owns about 6,000 shares of Pfizer Inc (PFE) stock worth over $172,680. Scott Gottlieb is also the Director of CombiMatrix Corp and owns about 4,804 shares of CombiMatrix Corp (CBMX) stock worth over $30,025. Details can be seen in Scott Gottlieb's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Gottlieb has not made any transactions after 2023-05-08 and currently still holds the listed stock(s).

Transaction Summary of Scott Gottlieb


Scott Gottlieb Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Gottlieb owns 4 companies in total, including Illumina Inc () , Pfizer Inc () , and CombiMatrix Corp () among others .

Click here to see the complete history of Scott Gottlieb’s form 4 insider trades.

Insider Ownership Summary of Scott Gottlieb

Ticker Comapny Transaction Date Type of Owner
Illumina Inc 2020-02-04 director
Pfizer Inc 2023-05-08 director
CombiMatrix Corp 2016-05-09 director
Targeted Medical Pharma Inc 2013-07-22 director

Scott Gottlieb Latest Holdings Summary

Scott Gottlieb currently owns a total of 2 stocks. Among these stocks, Scott Gottlieb owns 6,000 shares of Pfizer Inc (PFE) as of May 8, 2023, with a value of $172,680 and a weighting of 85.19%. Scott Gottlieb also owns 4,804 shares of CombiMatrix Corp (CBMX) as of May 9, 2016, with a value of $30,025 and a weighting of 14.81%.

Latest Holdings of Scott Gottlieb

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2023-05-08 6,000 28.78 172,680
CBMX CombiMatrix Corp 2016-05-09 4,804 6.25 30,025

Holding Weightings of Scott Gottlieb

Scott Gottlieb Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Gottlieb has made a total of 3 transactions in Pfizer Inc (PFE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Pfizer Inc is the acquisition of 2,000 shares on May 8, 2023, which cost Scott Gottlieb around $77,000.

According to the SEC Form 4 filings, Scott Gottlieb has made a total of 0 transactions in CombiMatrix Corp (CBMX) over the past 5 years. The most-recent trade in CombiMatrix Corp is the acquisition of 4,000 shares on May 9, 2016, which cost Scott Gottlieb around $12,120.

Insider Trading History of Scott Gottlieb

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Gottlieb Trading Performance

GuruFocus tracks the stock performance after each of Scott Gottlieb's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Gottlieb is 6.54%. GuruFocus also compares Scott Gottlieb's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Gottlieb within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott Gottlieb's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott Gottlieb

Average Relative Return


Average relative return per transaction

Outperforming Transactions


3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -0.56 6.54 -8.4 35.33 24.14 10.64
Relative Return to S&P 500(%) -0.96 3.38 -15.17 19.05 3.34 0.57

Scott Gottlieb Ownership Network

Ownership Network List of Scott Gottlieb

No Data

Ownership Network Relation of Scott Gottlieb

Scott Gottlieb Owned Company Details

What does Illumina Inc do?

Who are the key executives at Illumina Inc?

Scott Gottlieb is the director of Illumina Inc. Other key executives at Illumina Inc include SVP & Chief People Officer Aimee L Hoyt , director & Chief Executive Officer Jacob Thaysen , and SVP Product Development Susan H Tousi .

Illumina Inc () Insider Trades Summary

Over the past 18 months, Scott Gottlieb made no insider transaction in Illumina Inc (). Other recent insider transactions involving Illumina Inc () include a net sale of 9,250 shares made by Susan H Tousi , a net sale of 3,525 shares made by Aimee L Hoyt , and a net sale of 6,298 shares made by Alexander Aravanis .

In summary, during the past 3 months, insiders sold 315 shares of Illumina Inc () in total and bought 0 shares, with a net sale of 315 shares. During the past 18 months, 19,073 shares of Illumina Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,073 shares.

Illumina Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.


Illumina Inc Insider Transactions

No Available Data

Scott Gottlieb Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Gottlieb. You might contact Scott Gottlieb via mailing address: Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge Ma 02142.

Discussions on Scott Gottlieb

No discussions yet.